News

Sustained tuberculosis infection rates among adolescents were not lower following BCG revaccination vs placebo.
Here’s a look at Tuberculosis (also known as TB), an infection, caused by a bacterium called Mycobacterium tuberculosis, that usually affects the lungs. It can also infect other parts of the body ...
The BCG vaccine (Bacillus Calmette-Guérin) remains the only approved vaccine for tuberculosis (TB) prevention. Beyond TB, therapeutic applications of the BCG vaccine are expanding to include ...
(MENAFN- GlobeNewsWire - Nasdaq) The Therapeutic BCG Vaccine Market offers growth opportunities through expanding applications beyond TB prevention, including bladder cancer and autoimmune diseases.
[JONAH ONYANGO/STANDARD.] A nationwide shortage of Bacillus Calmette-Guerin (BCG) vaccines in the country leaves Kenyan newborns vulnerable to Tuberculosis (TB), a disease with a high prevalence ...
The trial of a 100-year-old tuberculosis (TB) vaccine in combating Covid-19 is currently underway with the first 500 medical staff already participating. The Bacille Calmette-Guerin (BCG) vaccine is ...
A recent study in Nature showed how BCG revaccination in adolescents boosts the identification of CD4+ T cell subsets, which may play a crucial role in immune protection against TB infection.
[Kipsang Joseph/Standard] A nationwide shortage of Bacillus Calmette-Guerin (BCG) vaccines is leaving Kenyan newborns vulnerable to Tuberculosis (TB), a disease with high prevalence, health ...
The bacillus Calmette–Guérin (BCG) vaccine, initially developed to provide protection against TB, also protects against leprosy; and the magnitude of this effect varies. Previous meta-analyses ...
Adding subcutaneous sasanlimab to BCG improved recurrence-free survival in non–muscle-invasive bladder cancer, according to Dr. Petros Grivas.
an advance on the current BCG vaccine which is not very effective and according to GSK “does not provide proven and consistent protection in adults in TB-endemic countries.” The big problem ...
The current live attenuated BCG vaccine has been in use since 1921 and, while it is effective in preventing severe TB disease in infants and young children, it provides limited protection against ...